Mycoplasma pneumoniae: re-emergence and beyond
Authors:
- Patrick M Meyer SauteurPSPatrick M Meyer Sauteur
- European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) Mycoplasma pneumoniae Surveillance (MAPS) study groupEGEuropean Society of Clinical Microbiology and Infectious Diseases Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) Mycoplasma pneumoniae Surveillance (MAPS) study group
Open Access
- 17 July 2025
- journal article
- Published by Elsevier in The Lancet Microbe
- Vol. 6 (11) , 101191
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Predicting the impact of non-pharmaceutical interventions against COVID-19 on Mycoplasma pneumoniae in the United StatesEpidemics, 2024
- Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniaeThe Lancet Microbe, 2024
- Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in ChinaThe Lancet Microbe, 2024